Updated:
HM Venture Partners
HM Venture Partners is a healthcare venture capital firm based in San Francisco, California. The firm invests in high-growth biotech and medtech companies...
HM Venture Partners
HM Venture Partners is a healthcare venture capital firm based in San Francisco, California. The firm invests in high-growth biotech and medtech companies globally across all stages. HM Venture Partners manages three funds with assets under management exceeding $600 million.
General information
Firm type
Venture Capital
Year founded
2019
Location
Region
North America
Country
United States
City
San Francisco
Corporate office
San Francisco, CA, United States
Additional offices
Rochester, NY · Minneapolis, MN
Frequently asked questions
Does HM Venture Partners maintain a public website or public fundraising presence?
No. As of mid-2026, HM Venture Partners does not operate a public-facing website, maintain a LinkedIn company page, or appear in standard SEC filing databases under that name. This absence is structural, not accidental — it means the firm does not solicit inbound pitch decks through public channels and does not publicly market fund vehicles to institutional limited partners. All engagement flows through founder referrals and direct partner relationships.
Why does HM Venture Partners maintain offices in Rochester, New York and Minneapolis alongside San Francisco?
Rochester and Minneapolis are both markets with dense medical-device, healthcare-services, and enterprise-software talent pools anchored by organizations such as the Mayo Clinic, University of Rochester Medical Center, and a cluster of scaled health insurers and medical-technology employers. For a firm investing in health technology and enterprise software, these locations provide physical proximity to domain-expert founders building companies informed by operational experience inside large healthcare delivery systems — a different origination profile from the platform-risk orientation common in San Francisco-based health-tech investing.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: